James Noble - Jul 1, 2021 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Director
Signature
/s/ James Julian Noble
Stock symbol
ADAP
Transactions as of
Jul 1, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 05:02 PM
Previous filing
May 7, 2021
Next filing
Jul 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADAP Option to purchase Ordinary Shares Award $0 +380K $0.00 380K Jul 1, 2021 Ordinary Shares 380K $0.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price was converted from GBP0.51 based on an exchange rate of $U.S. 1.3807 to GBP1.00. The actual exercise price will be the pounds sterling amount.